Novartis is thriving with double-digit growth, driven by key drugs in oncology, cardiology, immunology, and neurology. See ...

AMD has been gaining market share and faces better growth prospects than Nvidia beyond 2028. Check out the comparison between ...

Buffett's never been shy about going against what Wall Street is doing. Some of his best investments came from buying stocks ...

Sanjeev Prasad of Kotak advises lowering return hopes, rethinking risk, and ditching old valuation models in today’s ...